Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus in pS6+ Gastric Cancer
NCT01482299Phase 2Completed
- Sponsor
- Asan Medical Center
- Start
- Nov 2011
- Primary completion
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of everolimus in gastric cancer (GC), sponsored by Asan Medical Center. Started Nov 2011; status: completed.
02
Drugs
everolimus
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT01482299.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01482299.